Longevity Clinics Hybrid
Rank 16
Fountain Life
Real multi-city diagnostics days with published APEX/CORE fees — and the longevity chain MIT Technology Review used to illustrate unproven therapeutics.
Why it is here
Julie Bort at TechCrunch (13 Aug 2025) reported four operating centers (Naples, Orlando, Dallas, Westchester/White Plains), APEX at $21,500 a year, and CORE-like testing at $10,500, plus an $18 million raise. Jessica Hamzelou in MIT Technology Review (18 Apr 2025) cited Fountain in the $10,000–$150,000 annual range and, in a survey of 82 clinics, found stem cells, off-label drugs, and aesthetics mixed into the longevity offer, with no drug proven to extend human lifespan. Company cancer-detection and plaque-reversal marketing claims are not used as findings. The vendor site is supporting only. Miami and Los Angeles were planned, not confirmed open in the TechCrunch report.
Who it is for
Clients who want a US longevity-clinic membership with MRI on the diagnostics day, and who will treat the restorative/therapeutics layer as unproven.
Sources
- Tony Robbins and Peter Diamandis’ longevity company Fountain Life raises $18MFour centers; APEX $21,500; CORE-like testing $10,500.
- Longevity clinics around the world are selling unproven treatmentsFountain cited for pricing; survey of 82 clinics: unproven stem-cell and off-label drugs; no drug proven to extend human lifespan.
- Fountain LifeVendor site used as supporting confirmation of the multi-city diagnostics membership, not as an outcomes source.
